Abstract
Object
Subependymomas are rare ependymal neoplasms. To date, a large clinicopathologic study of these benign neoplasms treated with modern neurosurgical techniques has not been reported.
Methods
Eighty-three cases of subependymoma were retrieved from the files of the Armed Forces Institute of Pathology. Clinicopathological features were reviewed; chromogenic in situ hybridization analysis for chromosome 22 was performed (n = 8), and patient follow-up was obtained (n = 34). Overall, the patients included 68 males and 15 females, 1.5 to 85 years of age (mean, 51.0 years). Twenty-seven cases were discovered at autopsy and the remaining were surgical specimens (n = 56). Tumors arose in the posterior fossa (n = 43), lateral ventricles (n = 37), spinal cord (2) and only one arose in the temporal horn. Tumors ranged in size from 2.0 mm to 60 mm in greatest dimension (mean, 23.0 mm). Eighteen-percent (15/83) of subependymomas exhibited a mixed histologic pattern; that is, subependymoma together with another glial tumor. The most common mixture (13/15) was subependymoma and ependymoma. Surgical excision was used in all symptomatic patients; 10 patients received radiation. Four patients developed a recurrence due to incomplete excision. All patients were without evidence of disease at the last follow-up: alive (n = 28) or dead (n = 8).
Conclusions
Age is the only variable found to be significantly associated with survival. Currently, surgical methods result in an excellent long-term clinical outcome. Subependymomas do not appear to be associated with NF2 mutations.
Similar content being viewed by others
References
Brown DF, Rushing EJ (1999) Subependymomas: clinicopathologic study of 14 tumors. Arch Pathol Lab Med 123:873
Chiechi MV, Smirniotopoulos JG, Jones RV (1995) Intracranial subependymomas: CT and MR imaging features in 24 cases. AJR Am J Roentgenol 165:1245–1250
Dal Cin P, Van den Berghe H, Buonamici L et al (1999) Cytogenetic investigation in subependymoma. Cancer Genet Cytogenet 108:84
Ebert C, von Haken M, Meyer-Puttlitz B et al (1999) Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155:627–632
Furie D, Provenzale J (1995) Supratentorial ependymomas and subependymomas: CT and MR appearance. J Comput Assist Tomogr 19:518–526
Gaab MR, Schroeder HW (1998) Neuroendoscopic approach to intraventricular lesions. J Neurosurg 88:496–505
Hoeffel C, Boukobza M, Polivka M et al (1995) MR manifestations of subependymomas. AJNR Am J Neuroradiol 16:2121–2129
Im SH, Paek SH, Choi YL et al (2003) Clinicopathological study of seven cases of symptomatic supratentorial subependymoma. J Neurooncol 61:57–67
Jelinek J, Smirniotopoulos JG, Parisi JE et al (1990) Lateral ventricular neoplasms of the brain: differential diagnosis based on clinical, CT, and MR findings. AJNR Am J Neuroradiol 11: 567–574
Jooma R, Torrens MJ, Bradshaw J et al (1985) Subependymomas of the fourth ventricle. Surgical treatment in 12 cases. J Neurosurg 62:508–512
Lindboe C, Stolt-Nielsen A, Dale L (1992) Hemorrhage in a highly vascularized subependymoma of the septum pellucidum: case report. Neurosurgery 31:741–745
Lobato RD, Sarabia M, Castro S et al (1986) Symptomatic subependymoma: Report of four new cases studied with computed tomography and review of the literature. Neurosurgery 19:594–598
Lombardi D, Scheithauer BW, Meyer FB et al (1991) Symptomatic subependymoma: a clinicopathological and flow cytometric study. J Neurosurg 75:583–588
Maiuri G, Gangemi M, Iaconetta G et al (1997) Symptomatic subependymomas of the lateral ventricles. Report of eight cases. Clin Neurol Neurosurg 99:17–22
Peiro G, Mayr D, Hillemanns P et al (2004) Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome. Mod Pathol 17:227–287
Prayson RA, Suh JV (1999) Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms. Arch Pathol Lab Med 123:306–309
Ragel ET, Osborn AG, Townsend JJ et al (2006) Subependymomas: an analysis of clinical and imaging features. Neurosurgery 58:881–890
Rajaram V, Gutmann DH, Prasad SK et al (2005) Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. Mod Pathol 18:991–997
Rea GA, Akerson RD, Rockswold GL et al (1983) Subependymoma in a 2 1/2-year-old boy. Case report. J Neurosurg 59:1088–1091
Ryken TC, Robinson RA, VanGilder JA (1984) Familial occurrence of subependymoma. Report of two cases. J Neurosurg 80:1108–1111
Santi M, Quezado M, Ronchetti R et al (2005) Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization. J Neurooncol 72:25–28
Sceinker IM (1945) Subependymoma: a newly recognized tumor of subependymal derivation. J Neurosurg 2:232–240
Scheithauer BW (1978) Symptomatic subependymoma: Report of 21 cases with review of the literature. J Neurosurg 49:689–696
Shimada S, Ishizawa K, Horiguchi H et al (2003) Subependymoma of the spinal cord and review of the literature. Pathol Int 53:169–173
Spoto G, Press G, Hesselink J et al (1990) Intracranial ependymoma and subependymoma: MR manifestations. AJNR Am J Neuroradiol 11:83–91
Wiestler OD, Schiffer D (2000) Subependymoma. In: Kleihues P, Cavenee WK (eds) Tumors of the nervous system. Pathology and genetics. IARC Press, Lyon
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rushing, E.J., Cooper, P.B., Quezado, M. et al. Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neurooncol 85, 297–305 (2007). https://doi.org/10.1007/s11060-007-9411-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9411-6